SCHEDULE: Wellington Management Discloses Stake in Inspire Medical Systems

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 8.8% of Inspire Medical Systems, Inc. common stock as of March 31, 2026.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, have filed a Schedule 13G, indicating their beneficial ownership of Inspire Medical Systems, Inc. common stock.
• As of March 31, 2026, the aggregate beneficial ownership reported is 2,535,954 shares, representing approximately 8.8% of the class of securities.
• Wellington Management Company LLP holds shared voting and dispositive power over 2,470,848 shares and 2,489,312 shares, respectively, representing 8.6% of the class.
• The filing clarifies that the securities are owned by clients of one or more investment advisers identified in Item 7, and these clients have the right to receive dividends or proceeds from the sale of the securities. No single client is known to hold more than 5% of the class, with the exception of Vanguard Health Care Fund.
• The reporting entities are classified as investment advisers (IA) and holding companies (HC) for regulatory purposes.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant confidence from a major institutional investor, but it does not provide operational or financial updates.

Positives

• Significant institutional ownership by a reputable asset manager like Wellington Management can be seen as a positive signal of confidence in the company's long-term prospects.
• The filing indicates a substantial stake, suggesting a belief in the value and growth potential of Inspire Medical Systems.

Negatives

• The filing does not contain any negative financial results or operational challenges; it is purely an ownership disclosure.
• The disclosure of shared voting and dispositive power means that ultimate control rests with the individual clients, not solely with Wellington Management.

Risks

• While not explicitly stated as a risk in this filing, significant institutional ownership can sometimes lead to increased pressure on management to meet short-term performance expectations.
• The filing does not detail any specific risks related to Inspire Medical Systems' business operations or market position.

Future Outlook

This filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that significant institutional investment from firms like Wellington Management in medical device companies like Inspire Medical Systems often reflects a positive outlook on innovation and market penetration within the healthcare technology sector, particularly for companies addressing unmet medical needs.

Comparison to Industry Standards

• The 8.8% ownership stake by Wellington Management is a substantial position for an institutional investor in a publicly traded company. For comparison, average institutional ownership in the healthcare sector can vary widely, but a stake of this size typically signifies a significant conviction.
• Many successful medical device companies attract substantial investment from large asset managers, with stakes often ranging from 5% to over 20% for major institutional holders.
• Inspire Medical Systems operates in the sleep apnea device market, a segment that has seen considerable growth and competition from established players and innovative newcomers. The presence of a large investor like Wellington suggests the company is viewed as a competitive entity within this space.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive sign of confidence in the company's future.
• Management may feel increased scrutiny or pressure to perform due to the significant stake held by Wellington Management.

Next Steps

• Wellington Management will continue to hold its stake in Inspire Medical Systems, Inc.
• Further amendments to the Schedule 13G will be filed if beneficial ownership changes significantly.

Key Dates

Keywords

Inspire Medical Systems, Wellington Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Adviser, Healthcare Technology